AAPL337.08-2.67 (-0.79%) ▼|ABBV264.24-0.97 (-0.37%) ▼|ABT104.16+0.47 (+0.45%) ▲|ACN185.26+1.54 (+0.84%) ▲|ADBE240.26+2.01 (+0.84%) ▲|AMAT472.79+0.33 (+0.07%) ▲|AMD614.43-9.35 (-1.50%) ▼|AMGN407.75-2.49 (-0.61%) ▼|AMT172.04-3.21 (-1.83%) ▼|AMZN248.64-6.34 (-2.49%) ▼|AVGO355.06-9.48 (-2.60%) ▼|AXP303.20-1.87 (-0.61%) ▼|BA202.00+4.28 (+2.16%) ▲|BAC55.89-0.32 (-0.56%) ▼|BKNG156.76-7.46 (-4.54%) ▼|BLK1,067.24+0.58 (+0.05%) ▲|BMY61.61-0.65 (-1.04%) ▼|BNY150.52+0.35 (+0.23%) ▲|BRK-B511.02+7.53 (+1.50%) ▲|C132.65+0.18 (+0.13%) ▲|CAT810.34+2.33 (+0.29%) ▲|CL86.15-0.90 (-1.03%) ▼|CMCSA22.85+0.43 (+1.90%) ▲|COF197.49-3.06 (-1.53%) ▼|COP128.57+3.30 (+2.63%) ▲|COST901.17+1.76 (+0.20%) ▲|CRM239.38+6.10 (+2.61%) ▲|CSCO106.34-0.11 (-0.10%) ▼|CVS86.07-1.03 (-1.18%) ▼|CVX205.93+3.52 (+1.74%) ▲|DE708.94+5.82 (+0.83%) ▲|DHR220.84-0.25 (-0.11%) ▼|DIS103.99+0.17 (+0.16%) ▲|DUK114.87-1.45 (-1.24%) ▼|EMR155.51+1.32 (+0.86%) ▲|FDX293.60-2.34 (-0.79%) ▼|GD345.42+2.03 (+0.59%) ▲|GE321.18+1.96 (+0.61%) ▲|GEV942.18-8.10 (-0.85%) ▼|GILD150.73-1.94 (-1.27%) ▼|GM84.14+0.69 (+0.83%) ▲|GOOG335.45-11.96 (-3.44%) ▼|GOOGL339.03-12.13 (-3.45%) ▼|GS937.23-12.26 (-1.29%) ▼|HD299.87-5.49 (-1.80%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM235.07+3.69 (+1.59%) ▲|INTC120.60-3.26 (-2.63%) ▼|INTU287.63-4.72 (-1.61%) ▼|ISRG396.89-5.20 (-1.29%) ▼|JNJ267.24-1.96 (-0.73%) ▼|JPM338.26-1.74 (-0.51%) ▼|KO88.08-0.53 (-0.60%) ▼|LIN470.54+5.63 (+1.21%) ▲|LLY1,151.37-18.77 (-1.60%) ▼|LMT527.42+5.08 (+0.97%) ▲|LOW193.13-2.96 (-1.51%) ▼|LRCX306.87-3.76 (-1.21%) ▼|MA559.68+3.79 (+0.68%) ▲|MCD237.07-13.28 (-5.30%) ▼|MDLZ61.07-0.01 (-0.02%) ▼|MDT89.43-1.35 (-1.48%) ▼|META752.29+15.69 (+2.13%) ▲|MMM169.66+0.36 (+0.21%) ▲|MO69.46+0.82 (+1.19%) ▲|MRK147.99-2.93 (-1.94%) ▼|MS198.90-1.28 (-0.64%) ▼|MSFT499.40+1.40 (+0.28%) ▲|MU1,072.40-23.76 (-2.17%) ▼|NEE77.68-1.59 (-2.00%) ▼|NFLX71.68-0.48 (-0.67%) ▼|NKE35.85-0.25 (-0.69%) ▼|NOW140.10+3.10 (+2.26%) ▲|NVDA225.16-3.71 (-1.62%) ▼|ORCL146.47-2.73 (-1.83%) ▼|PEP129.78-1.41 (-1.07%) ▼|PFE28.18+0.25 (+0.88%) ▲|PG147.84-0.38 (-0.26%) ▼|PLTR191.18+6.19 (+3.35%) ▲|PM191.23+1.00 (+0.52%) ▲|QCOM197.30-0.97 (-0.49%) ▼|RTX193.90+2.91 (+1.52%) ▲|SBUX94.45-0.66 (-0.69%) ▼|SCHW100.26-0.09 (-0.09%) ▼|SO83.78-1.37 (-1.61%) ▼|SPG204.80-1.16 (-0.56%) ▼|T25.47+0.37 (+1.45%) ▲|TMO659.37+0.85 (+0.13%) ▲|TMUS166.52+4.11 (+2.53%) ▲|TSLA379.37+0.47 (+0.12%) ▲|TXN271.42+0.01 (+0.00%) ▲|UBER69.51-0.38 (-0.54%) ▼|UNH370.49-2.47 (-0.66%) ▼|UNP276.89+2.48 (+0.90%) ▲|UPS96.80+0.93 (+0.96%) ▲|USB58.91-0.54 (-0.90%) ▼|V361.86-0.18 (-0.05%) ▼|VZ46.90+0.45 (+0.97%) ▲|WFC82.36-0.79 (-0.95%) ▼|WMT110.27+0.15 (+0.14%) ▲|XOM160.94+2.23 (+1.41%) ▲|AAPL337.08-2.67 (-0.79%) ▼|ABBV264.24-0.97 (-0.37%) ▼|ABT104.16+0.47 (+0.45%) ▲|ACN185.26+1.54 (+0.84%) ▲|ADBE240.26+2.01 (+0.84%) ▲|AMAT472.79+0.33 (+0.07%) ▲|AMD614.43-9.35 (-1.50%) ▼|AMGN407.75-2.49 (-0.61%) ▼|AMT172.04-3.21 (-1.83%) ▼|AMZN248.64-6.34 (-2.49%) ▼|AVGO355.06-9.48 (-2.60%) ▼|AXP303.20-1.87 (-0.61%) ▼|BA202.00+4.28 (+2.16%) ▲|BAC55.89-0.32 (-0.56%) ▼|BKNG156.76-7.46 (-4.54%) ▼|BLK1,067.24+0.58 (+0.05%) ▲|BMY61.61-0.65 (-1.04%) ▼|BNY150.52+0.35 (+0.23%) ▲|BRK-B511.02+7.53 (+1.50%) ▲|C132.65+0.18 (+0.13%) ▲|CAT810.34+2.33 (+0.29%) ▲|CL86.15-0.90 (-1.03%) ▼|CMCSA22.85+0.43 (+1.90%) ▲|COF197.49-3.06 (-1.53%) ▼|COP128.57+3.30 (+2.63%) ▲|COST901.17+1.76 (+0.20%) ▲|CRM239.38+6.10 (+2.61%) ▲|CSCO106.34-0.11 (-0.10%) ▼|CVS86.07-1.03 (-1.18%) ▼|CVX205.93+3.52 (+1.74%) ▲|DE708.94+5.82 (+0.83%) ▲|DHR220.84-0.25 (-0.11%) ▼|DIS103.99+0.17 (+0.16%) ▲|DUK114.87-1.45 (-1.24%) ▼|EMR155.51+1.32 (+0.86%) ▲|FDX293.60-2.34 (-0.79%) ▼|GD345.42+2.03 (+0.59%) ▲|GE321.18+1.96 (+0.61%) ▲|GEV942.18-8.10 (-0.85%) ▼|GILD150.73-1.94 (-1.27%) ▼|GM84.14+0.69 (+0.83%) ▲|GOOG335.45-11.96 (-3.44%) ▼|GOOGL339.03-12.13 (-3.45%) ▼|GS937.23-12.26 (-1.29%) ▼|HD299.87-5.49 (-1.80%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM235.07+3.69 (+1.59%) ▲|INTC120.60-3.26 (-2.63%) ▼|INTU287.63-4.72 (-1.61%) ▼|ISRG396.89-5.20 (-1.29%) ▼|JNJ267.24-1.96 (-0.73%) ▼|JPM338.26-1.74 (-0.51%) ▼|KO88.08-0.53 (-0.60%) ▼|LIN470.54+5.63 (+1.21%) ▲|LLY1,151.37-18.77 (-1.60%) ▼|LMT527.42+5.08 (+0.97%) ▲|LOW193.13-2.96 (-1.51%) ▼|LRCX306.87-3.76 (-1.21%) ▼|MA559.68+3.79 (+0.68%) ▲|MCD237.07-13.28 (-5.30%) ▼|MDLZ61.07-0.01 (-0.02%) ▼|MDT89.43-1.35 (-1.48%) ▼|META752.29+15.69 (+2.13%) ▲|MMM169.66+0.36 (+0.21%) ▲|MO69.46+0.82 (+1.19%) ▲|MRK147.99-2.93 (-1.94%) ▼|MS198.90-1.28 (-0.64%) ▼|MSFT499.40+1.40 (+0.28%) ▲|MU1,072.40-23.76 (-2.17%) ▼|NEE77.68-1.59 (-2.00%) ▼|NFLX71.68-0.48 (-0.67%) ▼|NKE35.85-0.25 (-0.69%) ▼|NOW140.10+3.10 (+2.26%) ▲|NVDA225.16-3.71 (-1.62%) ▼|ORCL146.47-2.73 (-1.83%) ▼|PEP129.78-1.41 (-1.07%) ▼|PFE28.18+0.25 (+0.88%) ▲|PG147.84-0.38 (-0.26%) ▼|PLTR191.18+6.19 (+3.35%) ▲|PM191.23+1.00 (+0.52%) ▲|QCOM197.30-0.97 (-0.49%) ▼|RTX193.90+2.91 (+1.52%) ▲|SBUX94.45-0.66 (-0.69%) ▼|SCHW100.26-0.09 (-0.09%) ▼|SO83.78-1.37 (-1.61%) ▼|SPG204.80-1.16 (-0.56%) ▼|T25.47+0.37 (+1.45%) ▲|TMO659.37+0.85 (+0.13%) ▲|TMUS166.52+4.11 (+2.53%) ▲|TSLA379.37+0.47 (+0.12%) ▲|TXN271.42+0.01 (+0.00%) ▲|UBER69.51-0.38 (-0.54%) ▼|UNH370.49-2.47 (-0.66%) ▼|UNP276.89+2.48 (+0.90%) ▲|UPS96.80+0.93 (+0.96%) ▲|USB58.91-0.54 (-0.90%) ▼|V361.86-0.18 (-0.05%) ▼|VZ46.90+0.45 (+0.97%) ▲|WFC82.36-0.79 (-0.95%) ▼|WMT110.27+0.15 (+0.14%) ▲|XOM160.94+2.23 (+1.41%) ▲|
17.7 C
New York
Wednesday, September 23, 2026

Tag: program

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that dosing has commenced at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City, in its ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). This fifth site complements existing sites at Yale University, Johns Hopkins University, Brigham and Women's Hospital, and the University of Massachusetts.

Diagnostic Electrocardiograph/ECG Market worth US$15.18 billion by 2032 with 7.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., June 13, 2025 /PRNewswire/ -- The global Diagnostic Electrocardiograph/ECG Market, valued at US$8.59 billion in 2024 stood at US$9.19 billion in 2025 and...

Alectra releases 2024 ESG and GRE&T Centre reports highlighting commitment to sustainability, community support and grid modernization

MISSISSAUGA, Ontario, June 13, 2025 (GLOBE NEWSWIRE) -- Alectra Inc. presents its 2024 Annual Environmental, Social and Governance (ESG) Report, ‘Discover the Possibilities’, showcasing significant progress toward its long-term sustainability goals while continuing to deliver reliable, affordable energy services to more than one million homes and businesses across Ontario.

Digital Museums Canada’s 2025 Call for Proposals opens June 15

GATINEAU, QC, June 13, 2025 /CNW/ - The Digital Museums Canada 2025 Call for Proposals will open in two days! As of June 15,...

IoT Medical Devices Market worth US$154.74 billion by 2030 with 18.9% CAGR | MarketsandMarkets™.

DELRAY BEACH, Fla., June 13, 2025 /PRNewswire/ -- The global IoT Medical Devices Market, valued at US$53.78 billion in 2024 stood at US$65.08 billion in...

WALL STREET RAISES RECORD BREAKING $4.2 MILLION AT 15TH ANNUAL LEVERAGED FINANCE FIGHTS MELANOMA BENEFIT SUPPORTING THE MELANOMA RESEARCH ALLIANCE

NEW YORK, June 13, 2025 /PRNewswire/ -- More than 1,100 private equity leaders, financiers and attorneys packed the Museum of Modern Art on June...

Hard Rock Cafe’s Annual World Burger Tour Competition Brings Locally Inspired Burgers to Locations Around the World

Images here HOLLYWOOD, Fla., June 13, 2025 /PRNewswire/ -- Tomorrow, Hard Rock Cafe will kick off its annual World Burger Tour competition in celebration of Hard...

Hydration Room Expands to Rancho Cucamonga with New Wellness Clinic Focused on Proactive, Personalized Care

RANCHO CUCAMONGA, Calif., June 13, 2025 /PRNewswire/ -- Hydration Room, a leader in medically guided IV therapy and proactive wellness treatments, proudly announces the opening...

Baltimore Expands Use of Evolve™ Rodent Birth Control Following Successful Pilot

Full Scale Implementation Expected SURPRISE, Ariz., June 13, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control solutions...

Louis-César Pasquier appointed director of the INRS Centre Eau Terre Environnement

QUEBEC CITY, June 13, 2025 /CNW/ - Institut national de la recherche scientifique (INRS) is pleased to announce the appointment of Louis-César Pasquier as director of...

Celebrate Dad with Steak on the Grill

The Beef. It's What's For Dinner. brand shares a few recipes perfect for steak-lovers like dad. DENVER, June 13, 2025 /PRNewswire/ -- When it comes to...

Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib
New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib

Springview Holdings Ltd Achieves bizSAFE Level 4 Certification, Accelerating Growth and Expanding Market Reach

Singapore, June 13, 2025 (GLOBE NEWSWIRE) -- Springview Holdings Ltd (Nasdaq: SPHL) (“Springview Holdings”, or the “Company”), a leading designer and builder of residential and commercial properties in Singapore, today announced that its indirect wholly owned Singapore operating subsidiary, Springview Enterprises Pte. Ltd. (“Springview Singapore”) has been officially awarded bizSAFE Level 4 certification by the Workplace Safety and Health Council, effective June 9, 2025. This milestone marks a major leap forward in Springview Singapore’s journey toward operational excellence and sustainable growth.

Newfoundland and Labrador Police Officers Presented with MADD Canada’s Team Nick Coates Awards for Outstanding Road Safety Efforts

ST. JOHN'S, Newfoundland and Labrador, June 13, 2025 (GLOBE NEWSWIRE) -- Police officers across Newfoundland and Labrador will be recognized at MADD Canada’s seventh annual Team Nick Coates Awards ceremony for their outstanding efforts to remove impaired drivers from the province’s roadways, waterways, and trails.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgram